Mark Kozloff to Capecitabine
This is a "connection" page, showing publications Mark Kozloff has written about Capecitabine.
Connection Strength
0.054
-
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors. Invest New Drugs. 2014 Aug; 32(4):700-9.
Score: 0.028
-
Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours. Br J Cancer. 2012 Oct 09; 107(8):1268-76.
Score: 0.025